Updated Jul 16, 2026 · Last SEC filing 2026-06-10
COLLEGIUM PHARMACEUTICAL, INC (COLL) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-10. 4 Form 8-K material event filings were reported by COLL in the last 90 days. 5 Form 144 notices of proposed sale were filed for COLL stock. InsiderAlpha tracks every COLL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001267565 |
|---|
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 5 |
| Latest Form 4 filing | 2026-06-10 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| SANTINI GINO | Insider | M — Option exercise | 8.7K | $16.49 | $143K | SEC | |
| Freund John Gordon | Insider | S — Open-market sale | 20 | $34.05 | $681 | SEC | |
| Freund John Gordon | Insider | M — Option exercise | 8.7K | $16.49 | $143K | SEC | |
| Freund John Gordon | Insider | S — Open-market sale | 4.1K | $34.54 | $143K | SEC | |
| Paya Carlos V | Insider | A — Grant or award | 8.7K | $0.00 | — | SEC | |
| BOHLIN GAREN G | Insider | A — Grant or award | 8.7K | $0.00 | — | SEC | |
| Balice-Gordon Rita J. | Insider | A — Grant or award | 8.7K | $0.00 | — | SEC | |
| Glancy Donovan Michael | Insider | A — Grant or award | 17.5K | $0.00 | — | SEC | |
| SANTINI GINO | Insider | A — Grant or award | 8.7K | $0.00 | — | SEC | |
| Lurker Nancy | Insider | A — Grant or award | 8.7K | $0.00 | — | SEC | |
| Freund John Gordon | Insider | A — Grant or award | 8.7K | $0.00 | — | SEC | |
| Lurker Nancy | Insider | S — Open-market sale | 4.5K | $35.97 | $162K | SEC | |
| BOHLIN GAREN G | Insider | S — Open-market sale | 8.7K | $37.18 | $323K | SEC | |
| BOHLIN GAREN G | Insider | M — Option exercise | 8.7K | $16.49 | $143K | SEC | |
| Dieter David | EVP & General Counsel | S — Open-market sale [10b5-1] | 14.0K | $34.92 | $488K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for COLLEGIUM PHARMACEUTICAL, INC (COLL). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Freund John Gordon | 5 | $287K |
| BOHLIN GAREN G | 4 | $467K |
| SANTINI GINO | 3 | $143K |
| Lurker Nancy | 2 | $162K |
| Paya Carlos V | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in COLL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live COLL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.